| Bosutinib studied in …STUDIED_INderived41 of 41show fewer |
|---|
| → studied in | NCT06423911Phase 3 · recruiting Study of Olverembatinib (HQP1351) in Patients With CML-CP · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04971226Phase 3 · active not recruiting A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP · 41 trials list this drug (7 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03106779Phase 3 · completed Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs · 41 trials list this drug (7 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02501330completed Safety And Efficacy Of Bosutinib · 41 trials list this drug (7 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04877522Phase 4 · recruiting Asciminib Roll-over Study · 41 trials list this drug (7 active) | — | — | Leukemia,Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05363488completed Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland · 41 trials list this drug (7 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06297161recruiting A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML). · 41 trials list this drug (7 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03297606Phase 2 · recruiting Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) · 41 trials list this drug (7 active) | — | — | Solid Neoplasm,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03654768Phase 2 · active not recruiting Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia · 41 trials list this drug (7 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04258943Phase 1/Phase 2 · active not recruiting Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia · 41 trials list this drug (7 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03831776Phase 2 · completed Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03854903Phase 1 · completed WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor · 41 trials list this drug (7 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286528completed Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02546375completed A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311998Phase 1/Phase 2 · completed Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269267Phase 2 · completed The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) · 41 trials list this drug (7 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02810990Phase 2 · completed Bosutinib in Elderly Chronic Myeloid Leukemia · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03885830completed Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01903733NA · completed Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03023319Phase 1 · completed Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors · 41 trials list this drug (7 active) | — | — | Malignant Mesothelioma,Malignant Peritoneal Neoplasm,Malignant Thymus Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655391Phase 1 · withdrawn Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation · 41 trials list this drug (7 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03128411Phase 2 · completed Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia · 41 trials list this drug (7 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02228382Phase 4 · terminated Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00880009Phase 2 · terminated Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer · 41 trials list this drug (7 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02130557Phase 3 · completed A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia · 41 trials list this drug (7 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02782403Phase 1 · terminated Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638467Phase 2 · completed Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy · 41 trials list this drug (7 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04578847Phase 2 · unknown A Study of REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib) · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02906696Phase 2 · terminated Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure · 41 trials list this drug (7 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02445742Phase 2 · completed CML Treated With Bosutinib After Relapse · 41 trials list this drug (7 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574873Phase 3 · completed Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00261846Phase 2 · completed Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03205267Phase 2 · unknown Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients · 41 trials list this drug (7 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01331291Phase 2 · completed Bosutinib in Adult Patients With Recurrent Glioblastoma · 41 trials list this drug (7 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00959946Phase 1/Phase 2 · terminated Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer · 41 trials list this drug (7 active) | — | — | Malignant Breast Neoplasm,Glioblastoma,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00195260Phase 1 · completed Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors · 41 trials list this drug (7 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00793546Phase 2 · terminated Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer · 41 trials list this drug (7 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01374139Phase 1 · completed Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects · 41 trials list this drug (7 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01001936Phase 1 · completed Study Evaluating SKI-606 in Subject With Solid Tumors · 41 trials list this drug (7 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00759837Phase 1 · completed Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects · 41 trials list this drug (7 active) | — | — | Leukemia,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00777530Phase 1 · completed Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects · 41 trials list this drug (7 active) | — | — | Neoplasm,Leukemia,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |